The genotyping market is expected to grow from US$ 79,407.14 million in 2028 from US$ 25,191.28 million in 2022; it is estimated to grow at a CAGR of 20.1% during 2022–2028.
Genotyping is a process of studying the individual’s DNA sequence, and one can analyze the genetic differences through biological assays and for comparison with other individuals’ progression. Genotyping can help researchers study genetic deviations such as single nucleotide polymorphisms and significant structural changes in DNA. Human genotyping helps determine motherhood or fatherhood; Genotyping of micro-organisms, including bacteria and viruses.
The genotyping market is segmented into product and service, technology, application, end user, and geography. By geography, the market is broadly segmented into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. This report offers insights and in-depth analysis of the market, emphasizing parameters, such as market trends, market dynamics, and the competitive analysis of the globally leading market players.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Genotyping Market: Strategic Insights
Market Size Value in US$ 25,191.28 million in 2022 Market Size Value by US$ 79,407.14 million by 2028 Growth rate CAGR of 20.1% from 2022 to 2028. Forecast Period 2022-2028 Base Year 2022
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Genotyping Market: Strategic Insights
| Market Size Value in | US$ 25,191.28 million in 2022 |
| Market Size Value by | US$ 79,407.14 million by 2028 |
| Growth rate | CAGR of 20.1% from 2022 to 2028. |
| Forecast Period | 2022-2028 |
| Base Year | 2022 |
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Lucrative Regions for Genotyping Market
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Market Insights
Use of Genotyping in Drug Development for Genetic and Rare Diseases along with Technological Advancements and Rising R&D Investments in Pharmaceutical and Biotechnology to Drive Genotyping market
The players operating in the genotyping industry are focusing on increasing their investments in developing advanced biotechnological technologies as they offer a better alternative to conventional techniques. As these tests provide superior accuracy in disease diagnosis, the companies are looking forward to investing considerable money in product development. Additionally, growing research and development activities such as government funding for genome-based projects also contribute to the overall growth of the genotyping market. For instance, in September 2019, the UK government partnered with pharmaceutical firms and health experts and created a £200 million (USD 245.68 million) whole-genome sequencing project to examine and sequence the genetic code of 500,000 volunteers in the UK Biobank, based in Stockport. Such investments and developments in the genotyping market create significant growth opportunities for the market players.
A few examples of companies that have participated in developments are listed below:
- In May 2022, NEOGEN Corporation and Gencove announced the launch of InfiniSEEK, an innovative and cost-effective solution for solving Whole-genome sequencing and targeted SNP analysis.
- In July 2020, the enhanced version of the BD Onclarity HPV assay was FDA approved for premarket supplements and was the only assay currently approved to individually identify and report the genotype of human papillomavirus (HPV) 31, 51, 52, 33/58, 35/39/68, and 56/59/66. Standard 16, 18, and 45 versions were announced by Becton, Dickinson, and Company (BD).
- In June 2020, Illumina received the FDA Emergency Use Authorization for “COVIDSeq,” a Sequencing-Based COVID-19 Diagnostic Test. This test includes 98 amplicons to target the entire SARS-CoV-2 genome, creating efficient detection and high sensitivity.
- In March 2020, amplicon-based NGS panel, CleanPlex SARS-CoV-2 Panel for sequencing whole genome of SARS-COV-2 on both Illumina and MGI Tech Sequencing Platforms, developed by Paragon Genomics team. These panels were designed to get complete viral genomes even from samples with very low viral content.
- In November 2019, the US Food and Drug Administration approved the sale of a test to detect type 1 drug resistance mutations in the human immunodeficiency virus (HIV) using NGS technology. The Sentosa SQ HIV Genotyping Assay was the first HIV drug resistance assay using NGS technology and was approved by the FDA for sale in the United States.
Such developments by market players are driving the genotyping market.
Product and Services Insights
Based on the product and services, the genotyping market is segmented into instruments, reagents and kits, bioinformatics, and genotyping services. The reagent and kits segment will hold the largest market share in 2022. Moreover, the same segment is anticipated to register the highest CAGR during the forecast period due to the high demand by the consumers and the rising initiatives of market players in the launch and product expansion.
Genotyping Market, by Product and Services – 2022 and 2028
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Technology Insights
Based on Technology, the genotyping market is segmented into Microarrays, Capillary Electrophoresis, Sequencing, Matrix-Assisted Laser Desorption/Ionization-Time of Flight (Maldi-ToF), Mass Spectrometry, Polymerase Chain Reaction (PCR), and Others. In 2022, the polymerase chain reaction (PCR) segment will likely hold the market's largest share. Further, the Sequencing segment is expected to witness growth in its demand at the fastest CAGR from 2022 to 2028, owing to its higher specificity and capacity to detect the low expression and differentially expressed genes.
Application Insights
Based on application, the genotyping market is segmented into pharmacogenomics, diagnostics and personalized medicine, animal genetics, agricultural biotechnology, and others. In 2022, the diagnostics and personalized medicine segment is likely to hold the largest share of the market. Moreover, the Pharmacogenomics segment is also expected to witness growth in its demand at the fastest CAGR from 2022 to 2028, owing to more comprehensive, time- and cost-effective methods available and similar launches across the globe.
End User Insights
Based on end-user, the genotyping market is segmented into pharmaceutical and biopharmaceutical companies, diagnostic and research laboratories, academic institutes, and others. In 2022, the diagnostic and research laboratories segment is likely to hold the largest share of the market. Moreover, the Pharmaceutical and Biopharmaceutical Companies segment is expected to witness growth in its demand at the fastest CAGR from 2022 to 2028, owing to the rise in the number of products by Pharmaceutical and Biopharmaceutical Companies across the globe.
Organic developments such as product launches are highly adopted strategies by the global genotyping market players. A few of the recent key market developments are listed below:
In May 2022, Qiagen launched the QIAstat-Dx Rise syndromic testing platform that provides automated, comprehensive pathogen testing for higher-demand medical institutions. QIAstat-Dx Rise and its test cartridges are a closed system for hands-off sample preparation and processing. With a random-access capacity of up to 18 different tests, it can provide diagnostic results for up to 56 tests in an eight-hour shift and 160 tests per day by using eight analytical modules. Building on the existing QIAstat-Dx Analyzer with up to four analytical modules, QIAstat-Dx Rise is a flexible new option for increased testing capacity.
In Jan 2021, Thermo Fisher Scientific Inc., the world leader in serving science, is empowering scientists to drive groundbreaking discoveries by introducing new-generation mass spectrometry instruments, workflows, and software.
Genotyping – Market Segmentation
The global genotyping market is segmented into product and service, technology, application, end user, and geography. Based on Product and Service, the market is segmented into Instruments, Reagents and Kits, Bioinformatics, and Genotyping Services. Based on the Technology, the market is segmented into Microarrays, Capillary Electrophoresis, Sequencing, Polymerase Chain Reaction (PCR), and Matrix-Assisted Laser Desorption/Ionization-Time of Flight (Maldi-Tof) Mass Spectrometry, and Others. Based on Application, the market is differentiated into Pharmacogenomics, Diagnostics and Personalized Medicine, Animal Genetics, Agricultural Biotechnology, and Others. Based on End-User, the market is segmented into Pharmaceutical and Biopharmaceutical Companies, Diagnostic and Research Laboratories, Academic Institutes, and Others. By geography, the market is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America.
Company Profiles
- F. Hoffmann-La Roche Ltd.
- Integrated DNA Technologies, Inc.
- QIAGEN
- MERCK KGaA
- Eurofins Genomics
- Thermo Fisher Scientific Inc
- BioTek Instruments, Inc.
- Xcelris Genomics
- TrimGen Corporation
- Illumina, Inc.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Product and Service, Technology, Application, End-User and Geography
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
Frequently Asked Questions
In 2021, the polymerase chain reaction (PCR) held the largest share of the market by technology.
The genotyping market majorly consists of players such as F. Hoffmann-La Roche Ltd., Integrated DNA Technologies, Inc. (Danaher), Qiagen, Merck KGaA, Eurofins Genomics, Thermo Fisher Scientific Inc., BioTek Instruments, Inc., Xcelris Genomics, Trimgen Corporation, and Illumina, Inc.
F. HOFFMANN LA ROCHE LTD and Illumina, Inc.are the top two companies that hold huge market shares in the genotyping market.
In 2021, the reagents and kits segment accounted for the largest share of the market; it is further expected to continue its dominance over the forecast period. The major driving factor for the growth of the reagents and kits segment is the a wide range of genotyping kits is available from several major companies and these products make it easy to observe genetic variation in people, animals, organisms, and individual genes. Moreover, the various companies offer reagents and kits that are widely accepted by consumers is one of the significant factors in the growth of the reagents and kits segment.
Key factors driving the growth of this market are the use of genotyping in drug development for genetic and rare diseases and technological advancements and rising R&D investments in pharmaceutical and biotechnology expected to drive the market during the forecast period.
The CAGR value of the genotyping market during the forecasted period of 2021 to 2028 is 21.1%.
Genotyping is the technique of identifying the DNA sequence, or genotype, at particular locations across an individual's genome. In linkage and association studies, sequence variations can be employed as markers to find the genes responsible for certain characteristics or diseases. Understanding the relationship between genotypes and phenotypes requires knowledge of genotyping. When compared to a reference sequence that comes from the general population or a specific subgroup, an individual genome is recognized as a distinct variant. There are several ways in which a variant sequence might diverge from the reference sequence. Single nucleotide variations (SNV), single nucleotide polymorphisms (SNPs), insertions and deletions (indels), and copy number variation (CNV) are examples of genetic variation.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Genotyping Market – By Product and Service
1.3.2 Global Genotyping Market – By Technology
1.3.3 Global Genotyping Market – By Application
1.3.4 Global Genotyping Market – By End-User
1.3.5 Global Genotyping Market – By Geography
2. Genotyping Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Genotyping Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.2.2 Europe PEST Analysis
4.2.3 Asia Pacific PEST Analysis
4.2.4 Middle East and Africa PEST Analysis
4.2.5 South and Central America PEST Analysis
4.3 Experts Opinion
5. Genotyping Market– Key Market Dynamics
5.1 Market Drivers
5.1.1 Use of Genotyping in Drug Development for Genetic and Rare Diseases
5.1.2 Technological Advancements and Rising R&D Investments in Pharmaceutical and Biotechnology
5.2 Market Restraints
5.2.1 High Cost of Equipment and Shortage of skilled Professionals required for Genotyping process
5.3 Market Opportunities
5.3.1 Wide Applications of Genotyping
5.4 Future Trends
5.4.1 Rising focus on Personalized Medicine
5.5 Impact analysis
6. Genotyping Market– Global Analysis
6.1 Global Genotyping Market Revenue Forecast and Analysis
6.2 Global Genotyping Market, By Geography - Forecast and Analysis
6.3 Market Positioning of Key Players
6.4 Global Genotyping Market – Market Potential Analysis, By Region
6.5 Comparative Company Analysis
6.6 Growth Strategy Analysis
6.7 Performance of Key Players
6.7.1.1 F. Hoffmann-La Roche Ltd.
6.7.1.2 Illumina, Inc.
6.8 Market Share Analysis of Genotyping Market
7. Global Genotyping Market Revenue and Forecasts To 2028– by Product and Service
7.1 Overview
7.2 Global Genotyping Market, By Product and Service, 2022 & 2028 (%)
7.3 Reagents and Kits
7.3.1 Overview
7.3.2 Reagents and Kits: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
7.4 Genotyping Services
7.4.1 Overview
7.4.2 Genotyping Services: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
7.5 Bioinformatics
7.5.1 Overview
7.5.2 Bioinformatics: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
7.6 Instruments
7.6.1 Overview
7.6.2 Instruments: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
8. Genotyping Market Revenue and Forecasts To 2028 – Technology
8.1 Overview
8.2 Global Genotyping Market Share by Technology - 2022 & 2028 (%)
8.3 Polymerase Chain Reaction (PCR)
8.3.1 Overview
8.3.2 Polymerase Chain Reaction: Genotyping Market Revenue and Forecast to 2028 (US$ Million)
8.4 Capillary Electrophoresis (CE)
8.4.1 Overview
8.4.2 Capillary Electrophoresis: Genotyping Market Revenue and Forecast to 2028 (US$ Million)
8.5 Sequencing
8.5.1 Overview
8.5.2 Sequencing: Genotyping Market Revenue and Forecast to 2028 (US$ Million)
8.6 Microarrays
8.6.1 Overview
8.6.2 Microarrays: Genotyping Market Revenue and Forecast to 2028 (US$ Million)
8.7 Matrix-Assisted Laser Desorption/Ionization-Time of Flight (Maldi-Tof) Mass Spectrometry
8.7.1 Overview
8.7.2 Matrix-Assisted Laser Desorption/Ionization-Time of Flight (Maldi-Tof) Mass Spectrometry: Genotyping Market Revenue and Forecast to 2028 (US$ Million)
8.8 Others
8.8.1 Overview
8.8.2 Others: Genotyping Market Revenue and Forecast to 2028 (US$ Million)
9. Genotyping Market Revenue and Forecasts To 2028 – Application
9.1 Overview
9.2 Global Genotyping Market Share by Application - 2022 & 2028 (%)
9.3 Diagnostics and Personalized Medicine
9.3.1 Overview
9.3.2 Diagnostics and Personalized Medicine: Genotyping Market Revenue and Forecast to 2028 (US$ Million)
9.4 Pharmacogenomics
9.4.1 Overview
9.4.2 Pharmacogenomics: Genotyping Market Revenue and Forecast to 2028 (US$ Million)
9.5 Animal Genetics
9.5.1 Overview
9.5.2 Animal Genetics: Genotyping Market Revenue and Forecast to 2028 (US$ Million)
9.6 Agricultural Biotechnology
9.6.1 Overview
9.6.2 Agricultural Biotechnology: Genotyping Market Revenue and Forecast to 2028 (US$ Million)
9.7 Others
9.7.1 Overview
9.7.2 Others: Genotyping Market Revenue and Forecast to 2028 (US$ Million)
10. Genotyping Market Revenue and Forecasts To 2028 – End-User
10.1 Overview
10.2 Global Genotyping Market Share by End User- 2022 & 2028 (%)
10.3 Diagnostic and Research Laboratories
10.3.1 Overview
10.3.2 Diagnostic and Research Laboratories: Genotyping Market Revenue and Forecast to 2028 (US$ Million)
10.4 Pharmaceutical and Biopharmaceutical Companies
10.4.1 Overview
10.4.2 Pharmaceutical and Biopharmaceutical Companies: Genotyping Market Revenue and Forecast to 2028 (US$ Million)
10.5 Academic Institutes
10.5.1 Overview
10.5.2 Academic Institutes: Genotyping Market Revenue and Forecast to 2028 (US$ Million)
10.6 Others
10.6.1 Overview
10.6.2 Others: Genotyping Market Revenue and Forecast to 2028 (US$ Million)
11. Genotyping Market Revenue and Forecasts to 2028 – Geographical Analysis
11.1 North America: Genotyping Market Revenue and Forecasts To 2028
11.1.1 Overview
11.1.2 North America: Genotyping Market – Revenue and Forecast to 2028 (US$ Million)
11.1.3 North America: Genotyping Market, by Product and Services, 2019–2028 (US$ Million)
11.1.4 North America: Genotyping Market, by Technology, 2019–2028 (US$ Million)
11.1.5 North America: Genotyping Market, by Application, 2019–2028 (US$ Million)
11.1.6 North America: Genotyping Market, by End User, 2019–2028 (US$ Million)
11.1.7 North America: Genotyping Market, by Country, 2022 & 2028 (%)
11.1.7.1 US: Genotyping Market – Revenue and Forecast to 2028 (US$ Million)
11.1.7.1.1 Overview
11.1.7.1.2 US: Genotyping Market – Revenue and Forecast to 2028 (US$ Million)
11.1.7.1.3 US: Genotyping Market, by Product and Services, 2019–2028 (US$ Million)
11.1.7.1.4 US: Genotyping Market, by Technology, 2019–2028 (US$ Million)
11.1.7.1.5 US: Genotyping Market, by Application, 2019–2028 (US$ Million)
11.1.7.1.6 US: Genotyping Market, by End User, 2019–2028 (US$ Million)
11.1.7.2 Canada: Genotyping Market – Revenue and Forecast to 2028 (US$ Million)
11.1.7.2.1 Overview
11.1.7.2.2 Canada: Genotyping Market – Revenue and Forecast to 2028 (US$ Million)
11.1.7.2.3 Canada: Genotyping Market, by Product and Services, 2019–2028 (US$ Million)
11.1.7.2.4 Canada: Genotyping Market, by Technology, 2019–2028 (US$ Million)
11.1.7.2.5 Canada: Genotyping Market, by Application, 2019–2028 (US$ Million)
11.1.7.2.6 Canada: Genotyping Market, by End User, 2019–2028 (US$ Million)
11.1.7.3 Mexico: Genotyping Market – Revenue and Forecast to 2028 (US$ Million)
11.1.7.3.1 Overview
11.1.7.3.2 Mexico: Genotyping Market – Revenue and Forecast to 2028 (US$ Million)
11.1.7.3.3 Mexico: Genotyping Market, by Product and Services, 2019–2028 (US$ Million)
11.1.7.3.4 Mexico: Genotyping Market, by Technology, 2019–2028 (US$ Million)
11.1.7.3.5 Mexico: Genotyping Market, by Application, 2019–2028 (US$ Million)
11.1.7.3.6 Mexico: Genotyping Market, by End User, 2019–2028 (US$ Million)
11.2 Europe: Genotyping Market
11.2.1 Overview
11.2.2 Europe: Genotyping Market – Revenue and Forecast to 2028 (US$ Million)
11.2.3 Europe: Genotyping Market, by Product and Service – Revenue and Forecast to 2028 (US$ Million)
11.2.4 Europe: Genotyping Market, by Technology– Revenue and Forecast to 2028 (US$ Million)
11.2.5 Europe: Genotyping Market, by Application– Revenue and Forecast to 2028 (US$ Million)
11.2.6 Europe: Genotyping Market, by End User – Revenue and Forecast to 2028 (US$ Million)
11.2.7 Europe: Genotyping Market, by Country, 2021 & 2028 (%)
11.2.7.1 Germany: Genotyping Market – Revenue and Forecast to 2028 (US$ Million)
11.2.7.1.1 Overview
11.2.7.1.2 Germany: Genotyping Market – Revenue and Forecast to 2028 (US$ Million)
11.2.7.1.3 Germany: Genotyping Market, by Product and Service – Revenue and Forecast to 2028 (US$ Million)
11.2.7.1.4 Germany: Genotyping Market, by Technology– Revenue and Forecast to 2028 (US$ Million)
11.2.7.1.5 Germany: Genotyping Market, by Application– Revenue and Forecast to 2028 (US$ Million)
11.2.7.1.6 Germany: Genotyping Market, by End User – Revenue and Forecast to 2028 (US$ Million)
11.2.7.2 France: Genotyping Market – Revenue and Forecast to 2028 (US$ Million)
11.2.7.2.1 Overview
11.2.7.2.2 France: Genotyping Market – Revenue and Forecast to 2028 (US$ Million)
11.2.7.2.3 France: Genotyping Market, by Product and Service – Revenue and Forecast to 2028 (US$ Million)
11.2.7.2.4 France: Genotyping Market, by Technology– Revenue and Forecast to 2028 (US$ Million)
11.2.7.2.5 France: Genotyping Market, by Application– Revenue and Forecast to 2028 (US$ Million)
11.2.7.2.6 France: Genotyping Market, by End User – Revenue and Forecast to 2028 (US$ Million)
11.2.7.3 UK: Genotyping Market – Revenue and Forecast to 2028 (US$ Million)
11.2.7.3.1 Overview
11.2.7.3.2 UK: Genotyping Market – Revenue and Forecast to 2028 (US$ Million)
11.2.7.3.3 UK: Genotyping Market, by Product and Service – Revenue and Forecast to 2028 (US$ Million)
11.2.7.3.4 UK: Genotyping Market, by Technology– Revenue and Forecast to 2028 (US$ Million)
11.2.7.3.5 UK: Genotyping Market, by Application– Revenue and Forecast to 2028 (US$ Million)
11.2.7.3.6 UK: Genotyping Market, by End User – Revenue and Forecast to 2028 (US$ Million)
11.2.7.4 Italy: Genotyping Market – Revenue and Forecast to 2028 (US$ Million)
11.2.7.4.1 Overview
11.2.7.4.2 Italy: Genotyping Market – Revenue and Forecast to 2028 (US$ Million)
11.2.7.4.3 Italy: Genotyping Market, by Product and Service – Revenue and Forecast to 2028 (US$ Million)
11.2.7.4.4 Italy: Genotyping Market, by Technology– Revenue and Forecast to 2028 (US$ Million)
11.2.7.4.5 Italy: Genotyping Market, by Application– Revenue and Forecast to 2028 (US$ Million)
11.2.7.4.6 Italy: Genotyping Market, by End User – Revenue and Forecast to 2028 (US$ Million)
11.2.7.5 Spain: Genotyping Market – Revenue and Forecast to 2028 (US$ Million)
11.2.7.5.1 Overview
11.2.7.5.2 Spain: Genotyping Market – Revenue and Forecast to 2028 (US$ Million)
11.2.7.5.3 Spain: Genotyping Market, by Product and Service – Revenue and Forecast to 2028 (US$ Million)
11.2.7.5.4 Spain: Genotyping Market, by Technology– Revenue and Forecast to 2028 (US$ Million)
11.2.7.5.5 Spain: Genotyping Market, by Application– Revenue and Forecast to 2028 (US$ Million)
11.2.7.5.6 Spain: Genotyping Market, by End User – Revenue and Forecast to 2028 (US$ Million)
11.2.7.6 Rest of Europe: Genotyping Market – Revenue and Forecast to 2028 (US$ Million)
11.2.7.6.1 Overview
11.2.7.6.2 Rest of Europe: Genotyping Market – Revenue and Forecast to 2028 (US$ Million)
11.2.7.6.3 Rest of Europe: Genotyping Market, by Product and Service – Revenue and Forecast to 2028 (US$ Million)
11.2.7.6.4 Rest of Europe: Genotyping Market, by Technology– Revenue and Forecast to 2028 (US$ Million)
11.2.7.6.5 Rest of Europe: Genotyping Market, by Application– Revenue and Forecast to 2028 (US$ Million)
11.2.7.6.6 Rest of Europe: Genotyping Market, by End User – Revenue and Forecast to 2028 (US$ Million)
11.3 Asia Pacific Genotyping Market Revenue and Forecasts To 2028
11.3.1 Overview
11.3.2 Asia Pacific Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
11.3.3 Asia Pacific: Genotyping Market Revenue and Forecasts to 2028, By Product and Service (US$ Million)
11.3.4 Asia Pacific: Genotyping Market Revenue and Forecasts to 2028, By Technology (US$ Million)
11.3.5 Asia Pacific: Genotyping Market Revenue and Forecasts to 2028, By Application (US$ Million)
11.3.6 Asia Pacific: Genotyping Market Revenue and Forecasts to 2028, By End User (US$ Million)
11.3.7 Asia Pacific: Genotyping Market Revenue and Forecasts to 2028, By Country (%)
11.3.7.1 Japan: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
11.3.7.1.1 Overview
11.3.7.1.2 Japan: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
11.3.7.1.3 Japan: Genotyping Market Revenue and Forecasts to 2028, By Product and Service (US$ Million)
11.3.7.1.4 Japan: Genotyping Market Revenue and Forecasts to 2028, By Technology (US$ Million)
11.3.7.1.5 Japan: Genotyping Market Revenue and Forecasts to 2028, By Application (US$ Million)
11.3.7.1.6 Japan: Genotyping Market Revenue and Forecasts to 2028, By End User (US$ Million)
11.3.7.2 China: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
11.3.7.2.1 Overview
11.3.7.2.2 China: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
11.3.7.2.3 China: Genotyping Market Revenue and Forecasts to 2028, By Product and Service (US$ Million)
11.3.7.2.4 China: Genotyping Market Revenue and Forecasts to 2028, By Technology (US$ Million)
11.3.7.2.5 China: Genotyping Market Revenue and Forecasts to 2028, By Application (US$ Million)
11.3.7.2.6 China: Genotyping Market Revenue and Forecasts to 2028, By End User (US$ Million)
11.3.7.3 India Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
11.3.7.3.1 Overview
11.3.7.3.2 India: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
11.3.7.3.3 India: Genotyping Market Revenue and Forecasts to 2028, By Product and Service (US$ Million)
11.3.7.3.4 India: Genotyping Market Revenue and Forecasts to 2028, By Technology (US$ Million)
11.3.7.3.5 India: Genotyping Market Revenue and Forecasts to 2028, By Application (US$ Million)
11.3.7.3.6 India: Genotyping Market Revenue and Forecasts to 2028, By End User (US$ Million)
11.3.7.4 South Korea: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
11.3.7.4.1 Overview
11.3.7.4.2 South Korea: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
11.3.7.4.3 South Korea: Genotyping Market Revenue and Forecasts to 2028, By Product and Service (US$ Million)
11.3.7.4.4 South Korea: Genotyping Market Revenue and Forecasts to 2028, By Technology (US$ Million)
11.3.7.4.5 South Korea: Genotyping Market Revenue and Forecasts to 2028, By Application (US$ Million)
11.3.7.4.6 South Korea: Genotyping Market Revenue and Forecasts to 2028, By End User (US$ Million)
11.3.7.5 Australia: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
11.3.7.5.1 Overview
11.3.7.5.2 Australia: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
11.3.7.5.3 Australia: Genotyping Market Revenue and Forecasts to 2028, By Product and Service (US$ Million)
11.3.7.5.4 Australia: Genotyping Market Revenue and Forecasts to 2028, By Technology (US$ Million)
11.3.7.5.5 Australia: Genotyping Market Revenue and Forecasts to 2028, By Application (US$ Million)
11.3.7.5.6 Australia: Genotyping Market Revenue and Forecasts to 2028, By End User (US$ Million)
11.3.7.6 Rest of Asia Pacific: Genotyping Market – Revenue and Forecast to 2028 (US$ Million)
11.3.7.6.1 Overview
11.3.7.6.2 Rest of Asia Pacific: Genotyping Market – Revenue and Forecast to 2028 (US$ Million)
11.3.7.6.3 Rest of Asia Pacific: Genotyping Market Revenue and Forecasts to 2028, By Product and Service (US$ Million)
11.3.7.6.4 Rest of Asia Pacific: Genotyping Market Revenue and Forecasts to 2028, By Technology (US$ Million)
11.3.7.6.5 Rest of Asia Pacific: Genotyping Market Revenue and Forecasts to 2028, By Application (US$ Million)
11.3.7.6.6 Rest of Asia Pacific: Genotyping Market Revenue and Forecasts to 2028, By End User (US$ Million)
11.4 Middle East & Africa Genotyping Market Revenue and Forecasts To 2028
11.4.1 Overview
11.4.2 Middle East & Africa Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
11.4.3 Middle East & Africa: Genotyping Market Revenue and Forecasts to 2028, By Product and Services (US$ Million)
11.4.4 Middle East & Africa: Genotyping Market, by Technology, 2019–2028 (US$ Million)
11.4.5 Middle East & Africa: Metabolomics Market Revenue and Forecasts to 2028, By Application (US$ Million)
11.4.6 Middle East & Africa: Genotyping Market, by End User – Revenue and Forecast to 2028 (US$ Million)
11.4.7 Middle East & Africa Genotyping Market Revenue and Forecasts to 2028, By Country (%)
11.4.7.1 UAE: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
11.4.7.1.1 Overview
11.4.7.1.2 UAE: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
11.4.7.1.3 UAE: Genotyping Market Revenue and Forecasts to 2028, By Product and Services (US$ Million)
11.4.7.1.4 UAE: Genotyping Market, by Technology, 2019–2028 (US$ Million)
11.4.7.1.5 UAE: Genotyping Market Revenue and Forecasts To 2028, By Application (US$ Million)
11.4.7.1.6 UAE: Genotyping Market, by End User – Revenue and Forecast to 2028 (US$ Million)
11.4.7.2 Saudi Arabia: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
11.4.7.2.1 Overview
11.4.7.2.2 Saudi Arabia: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
11.4.7.2.3 Saudi Arabia: Genotyping Market Revenue and Forecasts to 2028, By Product and Services (US$ Million)
11.4.7.2.4 Saudi Arabia: Genotyping Market, by Technology, 2019–2028 (US$ Million)
11.4.7.2.5 Saudi Arabia: Genotyping Market Revenue and Forecasts To 2028, By Application (US$ Million)11.4.7.2.6 Saudi Arabia: Genotyping Market, by End User – Revenue and Forecast to 2028 (US$ Million)
11.4.7.3 South Africa: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
11.4.7.3.1 Overview
11.4.7.3.2 South Africa Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
11.4.7.3.3 South Africa: Genotyping Market Revenue and Forecasts to 2028, By Product and Services (US$ Million)
11.4.7.3.4 South Africa: Genotyping Market, by Technology, 2019–2028 (US$ Million)
11.4.7.3.5 South Africa: Metabolomics Market Revenue and Forecasts To 2028, By Application (US$ Million)
11.4.7.3.6 South Africa: Genotyping Market, by End User – Revenue and Forecast to 2028 (US$ Million)
11.4.7.4 Rest of Middle East and Africa: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
11.4.7.4.1 Overview
11.4.7.4.2 Rest of Middle East and Africa: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
11.4.7.4.3 Rest of Middle East & Africa: Genotyping Market Revenue and Forecasts to 2028, By Product and Services (US$ Million)
11.4.7.4.4 Rest of Middle East & Africa: Genotyping Market, by Technology, 2019–2028 (US$ Million)
11.4.7.4.5 Rest of Middle East & Africa: Genotyping Market Revenue and Forecasts To 2028, By Application (US$ Million)
11.4.7.4.6 Rest of Middle East and Africa: Genotyping Market, by End User – Revenue and Forecast to 2028 (US$ Million)
11.5 South And Central America Genotyping Market Revenue and Forecasts To 2028
11.5.1 Overview
11.5.2 South and Central America Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
11.5.3 South and Central America Genotyping Market Revenue and Forecasts to 2028, By Product and Service (US$ Million)
11.5.4 South and Central America: Genotyping Market Revenue and Forecasts to 2028, By Technology (US$ Million)
11.5.5 South and Central America: Genotyping Market Revenue and Forecasts to 2028, By Application (US$ Million)
11.5.6 South and Central America: Genotyping Market Revenue and Forecasts to 2028, By End User (US$ Million)
11.5.7 South and Central America Genotyping Market Revenue and Forecasts to 2028, By Country (%)
11.5.7.1 Argentina Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
11.5.7.1.1 Overview
11.5.7.1.2 Argentina Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
11.5.7.1.3 Argentina: Genotyping Market Revenue and Forecasts to 2028, By Product and Service (US$ Million)
11.5.7.1.4 Argentina: Genotyping Market Revenue and Forecasts To 2028, By Technology (US$ Million)
11.5.7.1.5 Argentina: Genotyping Market Revenue and Forecasts To 2028, By Application (US$ Million)
11.5.7.1.6 Argentina: Genotyping Market Revenue and Forecasts To 2028, By End User (US$ Million)
11.5.7.2 Brazil: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
11.5.7.2.1 Overview
11.5.7.2.2 Brazil: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
11.5.7.2.3 Brazil: Genotyping Market Revenue and Forecasts to 2028, By Product and Service (US$ Million)
11.5.7.2.4 Brazil: Genotyping Market Revenue and Forecasts To 2028, By Technology (US$ Million)
11.5.7.2.5 Brazil: Genotyping Market Revenue and Forecasts To 2028, By Application (US$ Million)
11.5.7.2.6 Brazil: Genotyping Market Revenue and Forecasts To 2028, By End User (US$ Million)
11.5.7.3 Rest of South and Central America: Genotyping Market– Revenue and Forecast to 2028 (USD Mn)
11.5.7.3.1 Overview
11.5.7.3.2 Rest of South and Central America: Genotyping Market– Revenue and Forecast to 2028 (USD Mn)
11.5.7.3.3 Rest of South & Central America: Genotyping Market Revenue and Forecasts to 2028, By Product and Service (US$ Million)
11.5.7.3.4 Rest of South & Central America: Genotyping Market Revenue and Forecasts To 2028, By Technology (US$ Million)
11.5.7.3.5 Rest of South & Central America: Genotyping Market Revenue and Forecasts To 2028, By Application (US$ Million)
11.5.7.3.6 Rest of South & Central America: Genotyping Market Revenue and Forecasts To 2028, By End User (US$ Million)
12. Impact Of COVID-19 Pandemic on Genotyping Market
12.1 North America: Impact Assessment of COVID-19 Pandemic
12.2 Europe: Impact Assessment of COVID-19 Pandemic
12.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
12.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
12.5 South and Central America: Impact Assessment of COVID-19 Pandemic
13. Genotyping Market Industry Landscape
13.1 Overview
13.2 Growth Strategies Done by the Companies in the Market, (%)
13.3 Organic Developments
13.3.1 Overview
13.4 Inorganic Developments
13.4.1 Overview
14. Company Profiles
14.1 F. HOFFMANN-LA ROCHE LTD.
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 INTEGRATED DNA TECHNOLOGIES, INC. (DANAHER)
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 QIAGEN
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 MERCK KGaA
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 EUROFINS GENOMICS
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 THERMO FISHER SCIENTIFIC INC.
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 BioTek Instruments, Inc.
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 XCELRIS GENOMICS
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 TRIMGEN CORPORATION
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Financial Overview
14.9.4 SWOT Analysis
14.9.5 Key Developments
14.10 Illumina, Inc.
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
15. Appendix
15.1 About The Insight Partners
15.2 Glossary of Terms
LIST OF TABLES
Table 1. The pharmaceutical company partnered with genomic health databases
Table 2. North America Genotyping Market, by Product and Services – Revenue and Forecast to 2028 (US$ Million)
Table 3. North America: Genotyping Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 4. North America Genotyping Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 5. North America Genotyping Market, by End User– Revenue and Forecast to 2028 (US$ Million)
Table 6. US Genotyping Market, by Product and Services – Revenue and Forecast to 2028 (US$ Million)
Table 7. US Genotyping Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 8. US Genotyping Market, by Application– Revenue and Forecast to 2028 (US$ Million)
Table 9. US Genotyping Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 10. Canada: Genotyping Market, by Product and Services – Revenue and Forecast to 2028 (US$ Million)
Table 11. Canada: Genotyping Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 12. Canada Genotyping Market, by Application– Revenue and Forecast to 2028 (US$ Million)
Table 13. Canada Genotyping Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 14. Mexico: Genotyping Market, by Product and Services – Revenue and Forecast to 2028 (US$ Million)
Table 15. Mexico: Genotyping Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 16. Mexico Genotyping Market, by Application– Revenue and Forecast to 2028 (US$ Million)
Table 17. Mexico Genotyping Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 18. Europe: Genotyping Market, by Product and Service – Revenue and Forecast to 2028 (US$ Million)
Table 19. Europe: Genotyping Market, by Technology– Revenue and Forecast to 2028 (US$ Million)
Table 20. Europe: Genotyping Market, by Application– Revenue and Forecast to 2028 (US$ Million)
Table 21. Europe: Genotyping Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 22. Germany: Genotyping Market, by Product and Service – Revenue and Forecast to 2028 (US$ Million)
Table 23. Germany: Genotyping Market, by Technology– Revenue and Forecast to 2028 (US$ Million)
Table 24. Germany: Genotyping Market, by Application– Revenue and Forecast to 2028 (US$ Million)
Table 25. Germany: Genotyping Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 26. France: Genotyping Market, by Product and Service – Revenue and Forecast to 2028 (US$ Million)
Table 27. France: Genotyping Market, by Technology– Revenue and Forecast to 2028 (US$ Million)
Table 28. France: Genotyping Market, by Application– Revenue and Forecast to 2028 (US$ Million)
Table 29. France: Genotyping Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 30. UK: Genotyping Market, by Product and Service – Revenue and Forecast to 2028 (US$ Million)
Table 31. UK: Genotyping Market, by Technology– Revenue and Forecast to 2028 (US$ Million)
Table 32. UK: Genotyping Market, by Application– Revenue and Forecast to 2028 (US$ Million)
Table 33. UK: Genotyping Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 34. Italy: Genotyping Market, by Product and Service – Revenue and Forecast to 2028 (US$ Million)
Table 35. Italy: Genotyping Market, by Technology– Revenue and Forecast to 2028 (US$ Million)
Table 36. Italy: Genotyping Market, by Application– Revenue and Forecast to 2028 (US$ Million)
Table 37. Italy: Genotyping Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 38. Spain: Genotyping Market, by Product and Service – Revenue and Forecast to 2028 (US$ Million)
Table 39. Spain: Genotyping Market, by Technology– Revenue and Forecast to 2028 (US$ Million)
Table 40. Spain: Genotyping Market, by Application– Revenue and Forecast to 2028 (US$ Million)
Table 41. Spain: Genotyping Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 42. Rest of Europe: Genotyping Market, by Product and Service – Revenue and Forecast to 2028 (US$ Million)
Table 43. Rest of Europe: Genotyping Market, by Technology– Revenue and Forecast to 2028 (US$ Million)
Table 44. Rest of Europe: Genotyping Market, by Application– Revenue and Forecast to 2028 (US$ Million)
Table 45. Rest of Europe: Genotyping Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 46. Asia Pacific: Genotyping Market Revenue and Forecasts to 2028, By Product and Service (US$ Million).
Table 47. Asia Pacific: Genotyping Market Revenue and Forecasts to 2028, By Technology (US$ Million)
Table 48. Asia Pacific: Genotyping Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 49. Asia Pacific: Genotyping Market Revenue and Forecasts to 2028, By End User (US$ Million)
Table 50. Japan: Genotyping Market Revenue and Forecasts to 2028, By Product and Service (US$ Million)
Table 51. Japan: Genotyping Market Revenue and Forecasts to 2028, By Technology (US$ Million)
Table 52. Japan: Genotyping Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 53. Japan: Genotyping Market Revenue and Forecasts to 2028, By End User (US$ Million)
Table 54. China: Genotyping Market Revenue and Forecasts to 2028, By Product and Service (US$ Million)
Table 55. China: Genotyping Market Revenue and Forecasts to 2028, By Technology (US$ Million)
Table 56. China: Genotyping Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 57. China: Genotyping Market Revenue and Forecasts to 2028, By End User (US$ Million)
Table 58. India: Genotyping Market Revenue and Forecasts to 2028, By Product and Service (US$ Million)
Table 59. India: Genotyping Market Revenue and Forecasts to 2028, By Technology (US$ Million)
Table 60. India: Genotyping Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 61. India: Genotyping Market Revenue and Forecasts to 2028, By End User (US$ Million)
Table 62. South Korea: Genotyping Market Revenue and Forecasts to 2028, By Product and Service (US$ Million)
Table 63. South Korea: Genotyping Market Revenue and Forecasts to 2028, By Technology (US$ Million)
Table 64. South Korea: Genotyping Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 65. South Korea: Genotyping Market Revenue and Forecasts to 2028, By End User (US$ Million)
Table 66. Australia: Genotyping Market Revenue and Forecasts to 2028, By Product and Service (US$ Million)
Table 67. Australia: Genotyping Market Revenue and Forecasts to 2028, By Technology (US$ Million)
Table 68. Australia: Genotyping Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 69. Australia: Genotyping Market Revenue and Forecasts to 2028, By End User (US$ Million)
Table 70. Rest of Asia Pacific: Genotyping Market Revenue and Forecasts to 2028, By Product and Service (US$ Million)
Table 71. Rest of Asia Pacific: Genotyping Market Revenue and Forecasts to 2028, By Technology (US$ Million)
Table 72. Rest of Asia Pacific: Genotyping Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 73. Rest of Asia Pacific: Genotyping Market Revenue and Forecasts to 2028, By End User (US$ Million)
Table 74. Middle East & Africa: Genotyping Market Revenue and Forecasts to 2028, By Product and Services (US$ Million)
Table 75. Middle East & Africa: Genotyping Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 76. Middle East & Africa: Metabolomics Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 77. Middle East & Africa: Genotyping Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 78. UAE: Genotyping Market Revenue and Forecasts to 2028, By Product and Services (US$ Million)
Table 79. UAE: Genotyping Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 80. UAE: Genotyping Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 81. UAE: Genotyping Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 82. Saudi Arabia: Genotyping Market Revenue and Forecasts to 2028, By Product and Services (US$ Million)
Table 83. Saudi Arabia: Genotyping Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 84. Saudi Arabia: Genotyping Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 85. Saudi Arabia: Genotyping Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 86. South Africa Genotyping Market Revenue and Forecasts to 2028, By Product and Services (US$ Million)
Table 87. South Africa: Genotyping Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 88. South Africa: Metabolomics Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 89. South Africa: Genotyping Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 90. Rest of Middle East & Africa: Genotyping Market Revenue and Forecasts to 2028, By Product and Services (US$ Million)
Table 91. Rest of Middle East & Africa: Genotyping Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 92. Rest of Middle East & Africa: Genotyping Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 93. Rest of Middle East and Africa: Genotyping Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 94. South and Central America Genotyping Market Revenue and Forecasts to 2028, By Product and Service (US$ Million)
Table 95. South and Central America: Genotyping Market Revenue and Forecasts to 2028, By Technology (US$ Million)
Table 96. South and Central America: Genotyping Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 97. South and Central America: Genotyping Market Revenue and Forecasts to 2028, By End User (US$ Million)
Table 98. Argentina: Genotyping Market Revenue and Forecasts to 2028, By Product and Service (US$ Million)
Table 99. Argentina: Genotyping Market Revenue and Forecasts to 2028, By Technology (US$ Million)
Table 100. Argentina: Genotyping Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 101. Argentina: Genotyping Market Revenue and Forecasts to 2028, By End User (US$ Million)
Table 102. Brazil: Genotyping Market Revenue and Forecasts to 2028, By Product and Service (US$ Million)
Table 103. Brazil: Genotyping Market Revenue and Forecasts to 2028, By Technology (US$ Million)
Table 104. Brazil: Genotyping Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 105. Brazil: Genotyping Market Revenue and Forecasts to 2028, By End User (US$ Million)
Table 106. Rest of South & Central America: Genotyping Market Revenue and Forecasts to 2028, By Product and Service (US$ Million)
Table 107. Rest of South & Central America: Genotyping Market Revenue and Forecasts to 2028, By Technology ( US$ Million)
Table 108. Rest of South & Central America: Genotyping Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 109. Rest of South & Central America: Genotyping Market Revenue and Forecasts to 2028, By End User (US$ Million)
Table 110. Organic Developments Done By Companies
Table 111. Inorganic Developments Done By Companies
Table 112. Glossary of Terms
LIST OF FIGURES
Figure 1. Genotyping Market Segmentation
Figure 2. Genotyping Market – By Geography
Figure 3. Genotyping Market Overview
Figure 4. Reagents and Kits Held Largest Share by Product and Services of Genotyping Market
Figure 5. Asia Pacific to Show Significant Growth During Forecast Period
Figure 6. Genotyping Market, by Geography (US$ Million)
Figure 7. Global Genotyping Market – Leading Country Markets (US$ Million)
Figure 8. Global Genotyping Market, Industry Landscape
Figure 9. North America: PEST Analysis
Figure 10. Europe: PEST Analysis
Figure 11. Asia Pacific: PEST Analysis
Figure 12. Middle East and Africa: PEST Analysis
Figure 13. South and Central America: PEST Analysis
Figure 14. Experts Opinion
Figure 15. Genotyping Market Impact Analysis of Driver and Restraints
Figure 16. Global Genotyping Market– Revenue Forecast and Analysis – 2022 - 2028
Figure 17. Global Genotyping Market – By Geography Forecast and Analysis – 2022 - 2028
Figure 18. Market Positioning of Key Players in Genotyping Market
Figure 19. Global Genotyping Market – Market Potential Analysis, By Region
Figure 20. Global Genotyping Market – Comparative Company Analysis
Figure 21. Global Genotyping Market – Growth Strategy Analysis
Figure 22. Market Share Analysis of Key Players in Global Genotyping Market
Figure 23. Global Genotyping Market, by Product and Service, 2022 & 2028 (%)
Figure 24. Reagents and Kits: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
Figure 25. Genotyping Services: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
Figure 26. Bioinformatics: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
Figure 27. Instruments: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
Figure 28. Global Genotyping Market Share by Technology - 2022 & 2028 (%)
Figure 29. Polymerase Chain Reaction: Genotyping Market Revenue and Forecasts To 2028 (US$ Million)
Figure 30. Capillary Electrophoresis: Genotyping Market Revenue and Forecasts To 2028 (US$ Million)
Figure 31. Sequencing: Genotyping Market Revenue and Forecasts To 2028 (US$ Million)
Figure 32. Microarrays: Genotyping Market Revenue and Forecasts To 2028 (US$ Million)
Figure 33. Matrix-Assisted Laser Desorption/Ionization-Time of Flight (Maldi-Tof) Mass Spectrometry: Genotyping Market Revenue and Forecasts To 2028 (US$ Million)
Figure 34. Others: Genotyping Market Revenue and Forecasts To 2028 (US$ Million)
Figure 35. Global Genotyping Market Share by Application - 2022 & 2028 (%)
Figure 36. Diagnostics and Personalized Medicine: Genotyping Market Revenue and Forecasts To 2028 (US$ Million)
Figure 37. Pharmacogenomics: Genotyping Market Revenue and Forecasts To 2028 (US$ Million)
Figure 38. Animal Genetics: Genotyping Market Revenue and Forecasts To 2028 (US$ Million)
Figure 39. Agricultural Biotechnology: Genotyping Market Revenue and Forecasts To 2028 (US$ Million)
Figure 40. Others: Genotyping Market Revenue and Forecasts To 2028 (US$ Million)
Figure 41. Global Genotyping Market Share by End User- 2022 & 2028 (%)
Figure 42. Diagnostic and Research Laboratories: Genotyping Market Revenue and Forecasts To 2028 (US$ Million)
Figure 43. Pharmaceutical and Biopharmaceutical Companies: Genotyping Market Revenue and Forecasts To 2028 (US$ Million)
Figure 44. Academic Institutes: Genotyping Market Revenue and Forecasts To 2028 (US$ Million)
Figure 45. Others: Genotyping Market Revenue and Forecasts To 2028 (US$ Million)
Figure 46. North America: Genotyping Market, by Key Country – Revenue (2021) (US$ Million)
Figure 47. North America Genotyping Market Revenue and Forecast to 2028 (US$ Million)
Figure 48. North America: Genotyping Market, by Country, 2022 & 2028 (%)
Figure 49. US: Genotyping Market – Revenue and Forecast to 2028 (US$ Million)
Figure 50. Canada: Genotyping Market – Revenue and Forecast to 2028 (US$ Million)
Figure 51. Mexico: Genotyping Market – Revenue and Forecast to 2028 (US$ Million)
Figure 52. Europe: Genotyping Market, by Key Country – Revenue (2021) (US$ Million)
Figure 53. Europe: Genotyping Market Revenue and Forecast to 2028 (US$ Million)
Figure 54. Europe: Genotyping Market, by Country, 2021 & 2028 (%)
Figure 55. Germany: Genotyping Market – Revenue and Forecast to 2028 (US$ Million)
Figure 56. France: Genotyping Market – Revenue and Forecast to 2028 (US$ Million)
Figure 57. UK: Genotyping Market – Revenue and Forecast to 2028 (US$ Million)
Figure 58. Italy: Genotyping Market – Revenue and Forecast to 2028 (US$ Million)
Figure 59. Spain: Genotyping Market – Revenue and Forecast to 2028 (US$ Million)
Figure 60. Rest of Europe: Genotyping Market – Revenue and Forecast to 2028 (US$ Million)
Figure 61. Asia Pacific Genotyping Market Overview, by Country (2021)
Figure 62. Asia Pacific: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
Figure 63. Asia Pacific: Genotyping Market Revenue and Forecasts to 2028, By Country (%)
Figure 64. Japan: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
Figure 65. China: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
Figure 66. India: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
Figure 67. South Korea: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
Figure 68. Australia: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
Figure 69. Rest of Asia Pacific: Genotyping Market – Revenue and Forecast to 2028 (US$ Million)
Figure 70. Middle East & Africa Genotyping Market Revenue Overview, by Country, 2021 (US$ Million)
Figure 71. Middle East & Africa Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
Figure 72. Middle East & Africa Genotyping Market Revenue and Forecasts to 2028, By Country (%)
Figure 73. UAE: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
Figure 74. Saudi Arabia: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
Figure 75. South Africa: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
Figure 76. Rest of Middle East and Africa: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
Figure 77. South and Central America Genotyping Market Revenue Overview, by Country, 2021 (US$ Million)
Figure 78. South and Central America Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
Figure 79. South and Central America Genotyping Market Revenue and Forecasts to 2028, By Country (%)
Figure 80. Argentina Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
Figure 81. Brazil: Genotyping Market Revenue and Forecasts to 2028 (US$ Million)
Figure 82. Rest of South and Central America: Genotyping Market– Revenue and Forecast to 2028 (USD Mn)
Figure 83. Impact of COVID-19 Pandemic in North American Country Markets
Figure 84. Impact of COVID-19 Pandemic in European Country Markets
Figure 85. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
Figure 86. Impact of COVID-19 Pandemic in Middle East and Africa Country Markets
Figure 87. Impact Of COVID-19 Pandemic in South and Central America Africa Country Markets
Figure 88. Growth Strategies Done by the Companies in the Market, (%)
The List of Companies - Genotyping Market
- F. Hoffmann-La Roche Ltd.
- Integrated DNA Technologies, Inc.
- QIAGEN
- MERCK KGaA
- Eurofins Genomics
- Thermo Fisher Scientific Inc
- BioTek Instruments, Inc.
- Xcelris Genomics
- TrimGen Corporation
- Illumina, Inc.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Genotyping Market
Jun 2022
Aquatic Veterinary Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Diagnostics and Treatments), Species (Fish, Crustaceans, Mollusca, and Others), Disease Source (Bacteria, Viruses, Parasites, and Others), Route of Administration (Water Medication, Medicated Feed, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jun 2022
Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis By Treatment (Generic Drugs and Originators), Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Jun 2022
Malaria and Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Treatment [Malaria and Sickle Cell Disease (SCD)], Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Jun 2022
Pharmaceutical Contract Sales Organizations Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Services (Commercial Services and Non-Commercial Services), Modules (Syndicated Modules and Dedicated Modules), Therapeutic Area (Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases, Infectious Diseases, and Others), End User (Biopharmaceutical Companies and Pharmaceutical Companies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jun 2022
Breast Cancer Therapeutics Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Drug Therapy [Targeted Drug Therapy (Abemaciclib, Ado-Trastuzumab Emtansine, Palbociclib, Trastuzumab, and Other Target Drug Therapies), Hormonal Drug Therapy (Selective Estrogen Receptor Modulators, Aromatase Inhibitors, and Selective Estrogen Receptor Downregulators), Chemotherapy, and Immunotherapy/Biological Therapy], Breast Cancer Type (Hormone Receptor, HER2+, and Triple-Negative Breast Cancer), Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, and Online Pharmacies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jun 2022
Radioactive Tracer Market
Size and Forecast to 2030 - Global Analysis by Tracer Type [Technetium-99m & Tc-97m, Iodine-131, Iron-59, Lutetium-171, Rubidium (Rb-82) Chloride & Ammonia (N-13), Scandium-46, Seaborgium-269, Hassium-269, Gallium Citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), Phosphorus-32 & Chromium-51, Thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and Others], Test Type (PET, SPECT, and Others), Application (Oncology, Pulmonary, Neurology, Cardiology, and Others) End User (Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, And Others), and Geography
Jun 2022
Glioma Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease (Astrocytoma, Oligoastrocytoma, and Oligodendroglioma), Treatment Type (Surgery, Chemotherapy, Radiation Therapy, and Others), Grade (Low Grade and High Grade), End User (Hospital & Clinics and Ambulatory Surgical Center), and Geography
Jun 2022
Hyperpigmentation Disorder Treatment Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Treatment Type (Cosmeceutical, Light or Laser Therapy, Microdermabrasion, Chemical Peels, Cryotherapy, and Others), Condition (Melasma, Solar Lentigines, Post-Inflammatory Hyperpigmentation, and Others), End User (Hospitals, Dermatology Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)